Synergy Mechanism
Wound healing stack. BPC-157 for angiogenesis, LL-37 for antimicrobial protection.
BPC-157 (upregulates vegfr2 to promote angiogenesis and activates the fak-paxillin pathway for accelerated tissue repair.) and LL-37 (human cathelicidin antimicrobial peptide that disrupts bacterial membranes, modulates tlr signaling, and promotes wound healing.) work through complementary pathways, producing a synergistic effect greater than either compound alone.
Combined Dosing Protocol
| Compound | Dose | Frequency | WADA |
|---|---|---|---|
| BPC-157 | 250mcg - 500mcg | 1-2x daily | |
| LL-37 | 100mcg - 500mcg | Daily or as per wound protocol |
Get This Protocol
Hatter Labs provides physician-supervised BPC-157 + LL-37 stack protocols with GMP-certified compounds.
Get ProtocolStart Your Performance Protocol for BPC-157 + LL-37 Stack
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised